Monopar Therapeutics Inc. (MNPR) financial statements and ratios from SEC XBRL: revenue $0.00 (latest fiscal year). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $0.00 |
| Price / Book | 5.54 |
| Price / Sales | 370.95 |
| Altman Z-Score | 149.97 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
MNPR overview · MNPR earnings · MNPR KPIs · MNPR documents · MNPR ownership · MNPR peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.